激活STING并克服使用ADC (抗体-药物联合体) 和其他输送系统的STING激动剂相关的挑战
Hitesh Vasiyani1, Bhumika Wadhwa2
1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA-23284, USA.
Cellular signalling
|February 8, 2025
概括
循环GMP-AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径是一个有前途的免疫治疗点. 输送系统对于克服癌症治疗中的STING激动剂挑战至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- cGAS-STING通路是免疫疗法的关键焦点,利用宿主免疫力通过STING激动剂对抗癌症.
- 循环二核酸 (CDN) 激活STING会触发1型干扰素反应和促炎细胞因子,增强抗瘤免疫力.
- 尽管临床前有希望,但STING激动剂面临挑战,包括药理动力学不佳,酶降解和导致自身免疫的非目标效应.
研究的目的:
- 审查包括直接和间接方法在内的STING激励策略.
- 讨论与癌症治疗中的STING激动剂相关的当前挑战.
- 探索正在进行的努力,在瘤微环境内开发有效的传递系统用于STING激动剂.
主要方法:
- 对STING通路激活机制和天然/合成激动剂的概述.
- 对现有STING激动剂的药理动力学,疗效和安全性限制的分析.
- 检查各种传递系统,包括非向载体 (纳米颗粒,水凝,小粒,脂质体) 和向传递 (ADC,体).
主要成果:
- 刺痛激动剂通过促进免疫细胞透和抗原呈现来激活对瘤的关键免疫反应.
- 自然CDN的药物动力学和酶的不稳定性很差,而合成激动剂会导致自身免疫的风险.
- 输送系统提供了一种可行的策略,以提高STING激动剂的药理动力学,疗效和安全性,在瘤微环境中.
结论:
- 刺痛激动剂在癌症免疫治疗中代表着一个重要的治疗途径.
- 克服STING激动剂的局限性需要创新的输送策略.
- 针对性和非针对性传递系统显示出改善基于STING激动剂的癌症治疗的前景.
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
720
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
720
01:30Adrenergic Agonists: Direct-Acting Agents
1.3K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.3K
01:25Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
01:22Drug Delivery: Miscellaneous Routes
305
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
305
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:18Adrenergic Agonists: Therapeutic Classification
699
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
699